Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

LGBTQ+

NHS Direct pilot to help treatment decisions

NHS Direct is piloting three online decision aids to help patients facing difficult decisions make informed healthcare choices

- PMLiVE

RCGP launches ‘Healthy Working UK’

The Royal College of General Practitioners has launched 'Healthy Working UK' – a website providing information concerning work and health

NICE recommends AZ’s Iressa for NSCLC

NICE has recommended AstraZeneca's Iressa as a first line treatment for non-small-cell lung cancer

The future for UK healthcare

A health bill that aims to create an NHS led by clinical decision makers will go before parliament in the next 18 months

MMR-autism ‘link’ doctor struck off

Dr Andrew Wakefield, who authored a 1998 Lancet study alleging a link between the MMR vaccine and autism, has been struck off by the GMC

UK government may end free drugs pricing

There are indications that free pricing for drugs may come under threat as part of cost-cutting processes by the Tory/Lib-Dem coalition government

Petition on Vidaza presented to No 10

A petition is being presented to the Prime Minister sparked by NICE's decision not to make Celgene's Vidaza available through the NHS

- PMLiVE

Andrew Lansley becomes Health Secretary

Andrew Lansley has been appointed as Secretary of State for Health, under the Conservative-Liberal Democrat coalition government

AZ lung cancer drug rejected in Scotland

AstraZeneca's lung cancer drug, Iressa, has not been accepted for use in Scotland by the Scottish Medicines Consortium

Promoting NHS and industry joint working

'The QIPP Challenge', an event to facilitate closer working between the NHS and the pharmaceutical industry, will be held in Bolton, UK in June

Swine flu may force PCTs to ‘cut services’

The cost of tackling the swine flu (H1N1) pandemic may lead to cuts in certain Primary Care Trust services in 2010/11

Levest COC promises NHS cost savings

Combined oral contraception, Levest, has won an NHS contract as the preferred drug of its type for hospitals in England

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links